Articles tagged with Lungs
A new study found significant regional differences in access to donor lungs for lung transplants in the US, with western states having lower availability. The revised lung allocation policy may exacerbate these disparities, prioritizing proximity to donors over patient needs.
A study has mapped the development of lung damage in young children with cystic fibrosis, revealing that immune abnormalities begin early in life and persist despite current treatments. The research found that targeted anti-inflammatory therapies may be necessary alongside existing medications to prevent permanent lung damage.
Experts from Mount Sinai will present a new AI model that predicts lung nodule risk and assesses the impact of air pollution during pregnancy. The researchers also explore cognitive consequences of sleep-disordered breathing and reevaluate asthma guidelines to integrate both conditions.
A study led by University of Arizona researchers found that azithromycin did not improve symptoms in preschool children with severe wheezing. The trial results challenge the idea that certain types of bacteria contribute to wheezing and asthma, suggesting that viral infections play a more significant role.
Researchers found that smoking substantially stiffens human lung parenchyma, making breathing progressively difficult. The study provides detailed mechanical data for human lungs, which may improve ventilator design and surgical planning tools.
A new study suggests that a visual measure of illness perception can effectively convey symptom-related quality of life for patients with chronic lung illnesses. The study found that patients' visual perceptions of their lung disease were equally effective as standard questionnaires and test results in predicting quality of life.
Researchers found a protein called RAB5c that helps white blood cells kill Aspergillus fumigatus, a common airborne fungus. Without this protein, immune cells are disarmed despite attacking at full force. The discovery could lead to new treatments for patients with weakened immune systems.
Researchers identified how Mycobacterium abscessus evades treatment and proposed a strategy to overcome resistance, offering a pathway towards more effective treatments. A combination therapy targeting both smooth and rough variants proved more effective than single-phage treatment.
A new study finds that pregnant women with low levels of a specific fatty acid molecule are more likely to have children with childhood asthma. The researchers also found that children of these mothers are more prone to respiratory infections and altered lung microbiomes.
A national survey of Australian tunnel construction workers found significant silica dust exposure risks, with many reporting barriers to effective dust control measures. The study calls for stronger regulatory enforcement and oversight to prevent preventable disease in the high-risk industry.
Researchers identified blocking ID1 and ID3 as a promising therapeutic strategy to halt and reverse lung scarring in idiopathic pulmonary fibrosis. The approach showed significant reduction in lung scarring and improvement in lung function across multiple experimental systems.
A study by Ebenbuild confirms strong predictive performance of patient-specific lung digital twins, validated against clinical imaging data. The model's accuracy was demonstrated through a correlation coefficient of 0.95 with experimental data, enabling locally resolved predictions of aerosol deposition at the individual patient level.
Researchers developed an inhaled treatment to reduce lung inflammation and fluid build-up after severe infections. The therapy targets Angiopoietin-like protein 4 (ANGPTL4) and showed promise in preclinical studies.
Chronic breathlessness affects people's sex life, leading to reduced satisfaction and intimacy. People with breathlessness are 1.5 times more likely to report dissatisfaction with their overall sexual life.
A multidisciplinary research team at Texas A&M University has developed a faster and more accurate test for determining the risks of airborne chemicals to human lungs. The study uses lab-grown lung cell models and found that common pollutants like acrolein and formic acid can damage respiratory barriers.
A new CRRT prediction model for AKI following lung transplantation identifies high-risk patients post-LTx, supporting timely intervention. The model integrates preoperative, intraoperative, and early postoperative indicators to estimate CRRT risk.
A long-term study found children living near the Salton Sea have slower lung function growth, with effects comparable to freeway exposure. The researchers controlled for various factors and found that dust exposure was linked to lower lung capacity, suggesting potential long-term health implications.
A retrospective study of 40 immunocompromised ICU patients found associations between low CD4+T-cell counts and specific lung pathogens. Patients with severe CD4 depletion had higher proportions of fungal infections, while moderate immunosuppression was linked to Streptococcus pneumoniae.
A new study by UC San Francisco reveals that aging lung tissue can lead to catastrophic immune dysregulation, causing elderly individuals to become severely ill. The research suggests that targeting the damaged spiral of inflammaging could provide a promising therapeutic target for treating age-related respiratory diseases.
A UK-led clinical trial found that surfactant treatment offers no benefit for infants on life support with severe bronchiolitis. The treatment was designed to improve recovery for critically ill babies, but the evidence does not support this.
A new study reveals that p38 MAPK plays a key role in epigenetic regulation of fibrotic genes in lung fibroblasts, particularly in senescent cells. Pharmacological inhibition of p38 MAPK significantly reduced α-SMA and Col3A1 expression, suggesting a potential therapeutic target for treating age-related fibrotic diseases like IPF.
Researchers found that exposure to microbes induces a lasting immune memory in fibroblasts, protecting lungs from allergic reactions for months. This discovery opens up new possibilities for developing preventive strategies for respiratory allergies.
A new study has confirmed that male and female lungs are wired differently at the molecular level, revealing key gene networks driving sex differences in respiratory health. The research found that male lungs are more reactive to environmental triggers, leading to different disease experiences between sexes.
Inhaled polystyrene nanoparticles induce lung injury by disrupting redox balance and triggering inflammation. Oxidative stress leads to mitochondrial dysfunction, respiration impairment, and apoptosis in lung cells.
A new study from National Jewish Health reveals that exposure to burn pit smoke and desert dust can damage the lungs of military service members. The research found that particles linked to burn pit exposure cause stronger inflammation and stress in lung immune cells, leading to chronic breathing problems.
A study published in EBioMedicine found changes in blood samples from almost 1,000 people hospitalized for COVID-19 may pinpoint patients at risk of long-term lung disease. The study identified elevated levels of certain molecules, which could lead to the development of simple blood tests to detect ongoing lung problems.
Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.
A study found that lung microbiomes play a significant role in pneumonia, with patients having oral-like pneumotypes more likely to recover. The researchers identified four distinct microbial patterns, or 'pneumotypes,' associated with different types of pneumonia.
Researchers create a simple, automated way of making lung organoids, which could help test early-stage experimental drugs more effectively. The bioreactor produces larger numbers of organoids with fewer manual labor requirements, offering promise for personalized patient treatments.
A European consortium developed a new decision-making framework to predict COPD exacerbation severity and prognostic risk, integrating three key factors: baseline health status, event intensity, and triggers. This framework, known as BAt model, aims to guide treatment strategies and improve consistency across clinical settings.
A cross-sectional survey of 29,268 participants found a significant association between dysfunctional breathing and respiratory conditions, as well as non-respiratory diseases like epilepsy. Tobacco use was also linked to increased prevalence of DB, particularly among those with comorbidities.
A recent study led by Dr. Leah Backhus found that lung cancer patients often receive inadequate posttreatment surveillance, which can lead to a substantial gap in care. The study estimated the true surveillance rates and predictors of guideline-concordant care in patients with early-stage non-small cell lung cancer.
A new study identifies fatty acid elongase ELOVL5 as a key promoter of inflammation resolution in the lungs. The research reveals that ELOVL5 works through a dual mechanism to dampen inflammatory pathways and generate pro-resolving lipid signals.
Researchers found that tubeless anesthesia significantly reduces postoperative complications, promotes enhanced recovery, and lowers costs in selected patients. The study also showed improved respiratory function and reduced intubation times.
The study demonstrated that nebulized HL231 at 261 µg/141 µg dose achieved comparable bronchodilation efficacy, pharmacokinetic profiles, and safety outcomes to Ultibro. HL231 showed a clear dose-response relationship with predominantly mild-to-moderate adverse events.
Researchers at UC Riverside discovered that two toxic chemicals can form when propylene glycol is heated, harming human lung cells. The chemicals, methylglyoxal and acetaldehyde, disrupt cell functions and cause damage even at low levels.
A new Northwestern University study reveals that abnormal cells in transplanted lungs engage in harmful 'conversations' with the immune system, leading to damage and rejection. The findings provide a comprehensive roadmap for treating chronic lung allograft dysfunction and other scarring lung diseases.
UCSF researchers found a key cellular switch driving pulmonary fibrosis and developed a new therapy to block it in mice. The treatment works by preventing healthy lung cells from converting to harmful cell types, reducing scarring and improving lung function.
The American College of Chest Physicians has designated October 19, 2025, as 'Love Your Lungs Day' in recognition of respiratory health. This initiative aims to raise awareness about lung diseases such as asthma and COPD, promoting equity and supporting healthcare providers.
Researchers aim to determine if biomarkers can identify adults at risk of developing interstitial lung disease (ILD), a chronic condition that causes inflammation and scarring in the lung tissue. The approach could lead to the development of new, better treatments with more tolerable side effects.
Denis Evseenko and Toby Maher are developing a regenerative drug to block cells that promote fibrosis in the lungs, aiming to slow or reverse IPF damage. The team plans to test the safety and therapeutic potential of their drug-like molecules in animals and human cells.
A new study from Trinity College Dublin finds that dexamethasone can reduce inflammation in TB patients while enhancing the function of their macrophages to kill Mycobacterium tuberculosis. The research suggests using steroids as an adjunct therapy in conjunction with existing treatments, particularly in cases with excessive inflammation.
Research shows that remote monitoring of children's asthma can prevent hospitalizations by around 57%. The system helps keep symptoms under control, leading to better outcomes and lasting self-management skills. This innovative approach could revolutionize healthcare services for patients with asthma.
A study found that people whose fathers began smoking at age 15 or younger show signs of faster biological aging compared to chronological age. This accelerated aging is linked to a higher risk of diseases such as cancer, arthritis, and dementia. The researchers call for stronger efforts to prevent tobacco use in teenagers.
Research presented at the European Respiratory Society Congress found that a healthy diet rich in fruits and vegetables can partially mitigate the adverse effects of air pollution on lung function. Women who consumed four portions of fruit per day or more appeared to have smaller reductions in lung function associated with air pollution.
Congenital diaphragmatic hernia is a deadly malformation of the lungs and diaphragm that causes underdeveloped lungs, leading to high mortality rates. Researchers discovered increased numbers of inflammatory cells in human lung tissue, both before and after birth, which may influence lung structure development.
A new study found that inhaling marijuana daily is associated with a 44% increased chance of developing asthma. Experts say people should avoid inhaling cannabis to reduce the risk of chronic lung disease. The study's authors emphasize the need for clearer messages about the risks of cannabis use.
Researchers at Tulane University have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, detecting TB in samples with very low levels of bacteria. The new test shows high sensitivity and accuracy, offering a significant step forward toward effective diagnoses via a variety of samples.
Researchers at UCalgary have found that neurons play a critical role in reducing harmful lung inflammation, which leads to pulmonary fibrosis. The discovery opens up opportunities for using neurological therapies to treat the disease, and preliminary studies suggest that boosting the function of these nerve cells could improve scarring.
A comprehensive state ban on flavored e-cigarettes leads to a decrease in vaping among young adults aged 18–24 years by about 2–3 percentage points, while increasing traditional cigarette use by a similar amount. For youth under 18, there is suggestive evidence of an increase in cigarette use, undermining broader tobacco control efforts.
A state ban on flavored e-cigarettes may lead to a net negative effect on health for young adults, increasing traditional cigarette use while reducing vaping. The study found that comprehensive bans had no impact on tobacco participation among adults aged 25 and older.
A new study will investigate whether low levels of the lung protein CC16 in childhood can predict who will develop early chronic obstructive pulmonary disease (COPD) later in life. The five-year study aims to identify children at risk for early COPD and potentially intervene to prevent lung disease.
Research shows that the 2025 Los Angeles wildfires resulted in an estimated 440 excess deaths, while the 2023 Maui wildfires led to immediate increases in suicide and overdose deaths. Higher social support was linked to improved mental health outcomes but did not buffer physiological effects.
The project aims to develop novel, interpretable biomarkers using advanced artificial intelligence to overcome limitations in current diagnostic tools. The team will integrate multi-modal data and biomechanics for better diagnosis and tracking of chronic obstructive pulmonary disease (COPD).
Researchers discovered that PAR1 triggers a structural transformation in lymphatic vessels, making them more permeable to absorb excess fluid and immune cells. This finding has implications for the treatment of lung diseases and could lead to targeted therapies.
A new study by Mass General Brigham investigators identified an ancient immune pathway that is activated in patients with acute chest syndrome (ACS) and serves as a key driver of the disease. Blocking this pathway with clinically approved drugs alleviated disease severity in preclinical models.
Researchers at Mount Sinai identified Epac1 as a key driver of idiopathic pulmonary fibrosis, a chronic and progressive lung-scarring disease. Blocking Epac1 with a small-molecule drug may slow the progression of the disease, offering new treatment options for patients.
A study found that exposure to β-glucan reprograms immune cells in the lungs, causing them to overreact and worsen lung damage. The research suggests that trained immunity in the lungs may have negative consequences in certain contexts.
Clinical trials show sutezolid and delpazolid are safer alternatives to linezolid for treating drug-resistant TB, with no cases of nerve damage or blood toxicity reported. The findings suggest these drugs could replace linezolid in treatment regimens.
Scientists from Pusan National University discovered a genetic biomarker, FCGBP, that is strongly linked to bronchiolitis obliterans syndrome and poor outcomes following lung transplantation. The finding may help identify high-risk patients and devise timely immunosuppressive treatments.